A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325)

From MaRDI portal
scientific article
Language Label Description Also known as
English
A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies
scientific article

    Statements

    A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (English)
    0 references
    22 October 2020
    0 references
    anti-angiogenic therapy
    0 references
    Hamiltonian
    0 references
    cancer treatment
    0 references
    fractional-calculus
    0 references
    delay differential equations
    0 references
    immunotherapy
    0 references
    optimal control
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references